Senior Scientist, Pre-Clinical Biology
Dr Jaclyn Sceneay is an immuno-oncologist with experience in small molecule and PROTAC drug discovery, and microbiome therapeutics.
Prior to BioCurate, Jaclyn has worked in biotechnology at both Seres Therapeutics and Bristol-Myers Squibb in Boston, Massachusetts. Jaclyn has experience leading cross-functional drug discovery programs from early target validation through hit-to-lead activities for SMI and PROTAC therapeutics, and in development of translational research models to perform IND-enabling studies for novel microbiome therapeutics.
Jaclyn completed her PhD at the University of Melbourne and the Peter MacCallum Cancer Centre, and undertook postdoctoral studies at both QIMR Berghofer Medical Research Institute in Brisbane, and the Brigham and Women’s Hospital in Boston, Massachusetts.